Publication: Identification Of Novel Disease Biomarkers In Systemic Sclerosis Through High-Throughput Proteomics
Loading...
Identifiers
Date
2022-06-01
Authors
Castro, R. Ortega
Pilar, F. U.
Martinez-Monllor, M.
Munoz-Barrera, L.
Sanchez-Pareja, I.
Abalos-Aguilera, M. C.
Puerto, N. Barbarroja
Estevez, E. Collantes
Aguirre-Zamorano, M. A.
Perez-Sanchez, C.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
BMJ Group
Metrics
Export
Abstract
Background: Systemic sclerosis (SSc) is an autoimmune disease characterized
by vasculopathy, tissue fibrosis and activation of the innate and adaptive immune system. Clinical features of the disease consist of skin thickening and internal organ involvement. Due to the heterogeneous nature of the disease, there is an unmet need of biomarkers for diagnosis, disease progression and response to treatment.
Description
MeSH Terms
Immune system
Biomarkers
Disease progression
Biomarkers
Disease progression
DeCS Terms
Biomarcadores
Progresión de la enfermedad
Sistema inmunológico
Progresión de la enfermedad
Sistema inmunológico
CIE Terms
Keywords
Scleroderma, systemic, Fibrosis, Autoimmune diseases
Citation
Castro RO, Pilar FU, Martinez-Monllor M, Muñoz-Barrera L, Sanchez-Pareja I, Ábalos-Aguilera MC, et al. POS0488 IDENTIFICATION OF NOVEL DISEASE BIOMARKERS IN SYSTEMIC SCLEROSIS THROUGH HIGH-THROUGHPUT PROTEOMICS. Annals Of The Rheumatic Diseases [Internet]. 23 de mayo de 2022;81(Suppl 1):498.3-499